Get the Stockscreener App
11.51
9.30%
-1.18
After Hours:
11.41
-0.10
-0.87%
Teladoc Health Inc stock is traded at $11.51, with a volume of 14.15M.
It is down -9.30% in the last 24 hours and up +21.16% over the past month.
Teladoc Health is a virtual health provider with a telehealth platform delivering on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio.
See More
Previous Close:
$12.69
Open:
$12.4
24h Volume:
14.15M
Relative Volume:
2.18
Market Cap:
$1.98B
Revenue:
$2.59B
Net Income/Loss:
$-981.73M
P/E Ratio:
-1.9948
EPS:
-5.77
Net Cash Flow:
$206.95M
1W Performance:
-19.68%
1M Performance:
+21.16%
6M Performance:
+55.96%
1Y Performance:
-26.41%
1-Day Range:
$11.34
$12.69
1-Week Range:
$11.34
$14.61
52-Week Range:
$6.76
$15.95
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
2 MANHATTANVILLE ROAD, PURCHASE, NY
Compare TDOC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
11.51 | 1.98B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
225.79 | 36.66B | 2.66B | 665.91M | 1.08B | 4.05 |
|
DOCS
Doximity Inc
|
72.37 | 13.58B | 516.85M | 174.11M | 217.38M | 0.87 |
|
SOLV
Solventum Corp
|
73.02 | 12.61B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
TEM
Tempus Ai Inc
|
68.09 | 10.72B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
108.60 | 9.41B | 1.15B | 96.70M | -161.99M | 1.09 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Teladoc Health Inc. (NYSE: TDOC) and Urges Investors with Substantial Losses to Contact the Firm - PR Newswire
What Analyst Projections for Key Metrics Reveal About Teladoc (TDOC) Q4 Earnings - Nasdaq
Why Teladoc Health, Inc. (TDOC) Crashed on Thursday - MSN
Telemedicine Market Projected to Reach USD 317.77 Billion by 2030 - openPR
TDOC INVESTIGATION: Teladoc Health, Inc. Investigated For - GlobeNewswire
TDOC INVESTIGATION: Teladoc Health, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm - GlobeNewswire
TDOC INVESTIGATION: Teladoc Health, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm - GlobeNewswire Inc.
Levi & Korsinsky Notifies Shareholders of Teladoc Health, Inc.(TDOC) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Telepsychiatry Market Set for Explosive Growth: USD 7.34B to USD 41.59B by 2032 - EIN News
Teladoc Health: Needs A Growth Catalyst (NYSE:TDOC) - Seeking Alpha
Why Teladoc Health (TDOC) Crashed on Tuesday? - MSN
Sector Update: Health Care Stocks Advance Late Afternoon - TradingView
10 Best Performing Healthcare Stocks So Far in 2025 - Insider Monkey
Teladoc Health, Inc. (TDOC): the Best Performing Healthcare Stock So Far in 2025 - Insider Monkey
Teladoc stock fluctuates amid short-seller claim - Investing.com India
Blue Orca Capital Says We Are Short Teladoc Health- X Post -February 19, 2025 at 12:08 pm EST - Marketscreener.com
Teladoc Health: Amazon To The Rescue, Potentially (NYSE:TDOC) - Seeking Alpha
Best Telemedicine Services for 2025 - CNET
Extensive Growth Opportunities to be Witnessed by Virtual - openPR
New Horizons in Digital Telehealth Behavior Transformation - openPR
Teladoc's SWOT analysis: virtual care leader faces growth hurdles - Investing.com
Teladoc Partners With Amazon to Expand Chronic Care Program Reach - MSN
Entropy Technologies LP Sells 93,877 Shares of Teladoc Health, Inc. (NYSE:TDOC) - MarketBeat
Is Teladoc Stock a Buy? - MSN
Teladoc Health To Buy Catapult Health In $65 Million Deal - Pulse 2.0
Donna Cusano - Telehealth and Telecare Aware
Page 17 | TELADOC HEALTH INC.DL-001 Trade Ideas — DUS:4LL - TradingView
Teladoc Health (NYSE:TDOC) Price Target Raised to $13.50 at Bank of America - MarketBeat
(TDOC) Proactive Strategies - Stock Traders Daily
Teladoc Health (TDOC) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Why Teladoc Health Stock Crashed Again in 2024 - AOL
Top 10 Health Information Services Stocks Outpacing The Market In 2025 - Insider Monkey
Teladoc Health (NYSE:TDOC) Stock Price Up 9%Time to Buy? - MarketBeat
Teladoc Health, Inc. (TDOC): Among the Health Information Services Stocks Outpacing the Market in 2025 - Insider Monkey
Virtual-First Care Market Growing Trends and Demands Analysis - openPR
BofA raises Teladoc stock price target to $13.50, keeps neutral rating - MSN
Online Doctor Consultation Market Insights and Growth - openPR
C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Buys Shares of 29,882 Teladoc Health, Inc. (NYSE:TDOC) - MarketBeat
Teladoc Health (NYSE:TDOC) Stock Price Down 5%Here's What Happened - MarketBeat
Why Teladoc Health (TDOC) Soared Last Week? - MSN
Interesting TDOC Put Options For April 4th - Nasdaq
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.80%
2.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):